Pharmaceuticals

Global Post-Marketing Pharmacovigilance And Medical Information Market Report 2026–2035: Key Forecasts and Growth Areas

February 18, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the post-marketing pharmacovigilance and medical information market from 2026–2035 with trusted insights from The Business Research Company

What are the forecasted starting (2026) and ending (2030) market sizes for the Post-Marketing Pharmacovigilance And Medical Information Market?

The post-marketing pharmacovigilance and medical information market size has experienced rapid growth in recent years. This market is set to expand from $6.9 billion in 2025 to $7.71 billion in 2026, achieving a compound annual growth rate (CAGR) of 11.7%. Historically, this growth has been influenced by factors including limited post-marketing surveillance infrastructure, a reliance on manual adverse drug reaction (ADR) reporting, increasing regulatory mandates for drug safety, a greater number of new drug approvals, and a lack of integrated hospital data systems.

The post-marketing pharmacovigilance and medical information market is projected to experience substantial expansion over the coming years. Its valuation is set to reach $11.89 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 11.4%. This projected growth can be ascribed to several factors, including the incorporation of AI and ML algorithms in signal detection, the uptake of longitudinal patient data analysis, the broadening of disease registry-linked monitoring, the rise in digital application-based reporting, and increased investments in real-time pharmacovigilance technologies. Key trends anticipated during this period encompass the growing embrace of electronic health record (EHR) mining, the escalating utilization of real-time adverse drug reaction (ADR) monitoring systems, an increase in reporting based on risk populations and therapeutic classes, the expansion of cohort event monitoring for new drug users, and the integration of digital and mobile platforms for pharmacovigilance reporting.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27393&type=smp

What Drivers Are Supporting Technological Adoption In The Post-Marketing Pharmacovigilance And Medical Information Market?

The increasing occurrence of adverse drug reactions is projected to propel the expansion of the post-marketing pharmacovigilance and medical information market in the future. Adverse drug reactions are defined as detrimental or unforeseen effects that appear when a drug is administered at its recommended dosage for preventive, diagnostic, or therapeutic objectives. The frequency of these reactions is escalating because the aging population increasingly requires interventions for numerous chronic conditions, leading to the simultaneous use of various medications which heightens the potential for dangerous drug interactions and unanticipated side effects. Post-marketing pharmacovigilance and medical information assist in managing adverse drug reactions by identifying, monitoring, and disseminating details on possible side effects once a medication is introduced to the market, thereby helping to maintain its ongoing safety and effectiveness. For instance, in January 2023, according to Navikenz, a US-based artificial intelligence-focused IT services company, in the US, adverse drug reactions are estimated to cause 200,000 to 400,000 deaths annually, exceeding the combined mortality from stroke and diabetes, with approximately 2.7 million annual cases resulting in over 100,000 hospitalizations and more than 15,000 fatalities. Consequently, the escalating incidence of adverse drug reactions is driving the growth of the post-marketing pharmacovigilance and medical information market.

What Segment Types Are Examined In The Post-Marketing Pharmacovigilance And Medical Information Market?

The post-marketing pharmacovigilance and medical information market covered in this report is segmented –

1) By Type: Spontaneous Reporting, Intensified Adverse Drug Reaction (ADR) Reporting, Targeted Spontaneous Reporting, Cohort Event Monitoring, Electronic Health Record (EHR) Mining

2) By Publication Type: Books, Online Media, Journals

3) By End User: Hospitals, Research Organizations, Other End-Users

Subsegments:

1) By Spontaneous Reporting: Consumer Reporting, Healthcare Professional Reporting, Regulatory Authority Reporting, Pharmaceutical Company Reporting, Digital App-Based Reporting

2) By Intensified Adverse Drug Reaction (ADR) Reporting: Hospital-Based Surveillance, Program-Specific Monitoring, Disease-Specific Monitoring, Product-Specific Monitoring, Real-Time Monitoring Systems

3) By Targeted Spontaneous Reporting: Risk Population-Based Reporting, Therapeutic Class-Based Reporting, Adverse Drug Reaction Focused Reporting, Region-Specific Reporting, Healthcare Setting-Specific Reporting

4) By Cohort Event Monitoring: Prospective Cohort Monitoring, Retrospective Cohort Monitoring, Active Follow-Up Monitoring, New Drug User Monitoring, Disease Registry-Linked Monitoring

5) By Electronic Health Record (EHR) Mining: Natural Language Processing-Based Mining, Artificial Intelligence (AI) And Machine Learning Algorithms, Rule-Based Signal Detection, Longitudinal Patient Data Analysis, Integrated Hospital Data Systems

Which Trends Are Guiding The Evolution Of The Post-Marketing Pharmacovigilance And Medical Information Market?

Leading businesses within the post-marketing pharmacovigilance and medical information market are concentrating their efforts on creating sophisticated tools, including AI-driven pharmacovigilance processes. This endeavor seeks to boost the precision of adverse event identification and facilitate continuous safety oversight, ultimately improving patient well-being. These AI-enhanced pharmacovigilance workflows leverage artificial intelligence to automate the surveillance of drug safety, thereby accelerating the identification of adverse events and strengthening adherence to regulations. As an illustration, PubHive Ltd., a UK-based cloud software-as-a-service (SaaS) firm, launched a unified Summary of Product Characteristics (SmPC) management solution in January 2024, designed for life science companies and research entities. This platform unifies essential drug safety data into a singular, readily available repository. It also automates the monitoring of scientific literature and regulatory reporting, fosters improved team cooperation, and optimizes compliance procedures through its cutting-edge AI functionalities. Consequently, pharmacovigilance teams can operate with greater efficiency and foresight, guaranteeing both patient safety and conformity to regulatory requirements.

Who Are The Primary Competitors In The Global Post-Marketing Pharmacovigilance And Medical Information Market?

Major companies operating in the post-marketing pharmacovigilance and medical information market are Accenture plc, Sanofi S.A., Capgemini SE, Merck & Co. Inc., Cognizant Technology Solutions Corporation, IQVIA Holdings Inc., HCL Technologies Limited, ICON plc, Syneos Health Inc., Genpact Limited, Parexel International Corporation, Avalere Health LLC, Quanticate Limited, Inizio Consulting LLC

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/post-marketing-pharmacovigilance-and-medical-information-global-market-report

Which Global Regions Are Shaping The Competitive Landscape Of The Post-Marketing Pharmacovigilance And Medical Information Market?

North America was the largest region in the post-marketing pharmacovigilance and medical information market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the post-marketing pharmacovigilance and medical information market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Post-Marketing Pharmacovigilance And Medical Information Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=27393&type=smp

Browse Through More Reports Similar to the Global Post-Marketing Pharmacovigilance And Medical Information Market 2026, By The Business Research Company

Drain Cleaning Equipment Market Report 2026

https://www.thebusinessresearchcompany.com/report/drain-cleaning-equipment-global-market-report

Urinary Drainage Bags Market Report 2026

https://www.thebusinessresearchcompany.com/report/urinary-drainage-bags-global-market-report

Prefabricated Buildings Market Report 2026

https://www.thebusinessresearchcompany.com/report/prefabricated-buildings-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info